Direttore sanitario: Dott.ssa Cinchini Elisabetta

Quisisana

HIGH PREVALENCE OF CENTRAL HYPOTHYROIDISM IN ADULT PATIENTS WITH β-THALASSEMIA MAJOR

De Sanctis V, Soliman A, Candini G, Campisi S, Anastasi S, Yassin M.

 

Pediatric and Adolescent Outpatient Clinic, Quisisana Hospital, Ferrara, Italy; Department of Pediatrics, Hamad Medical Center (HMC), Doha, Qatar; Department of Medical Physics, St.Anna Hospital, Ferrara, Italy; Unit for the Diagnosis and Treatment of Thalassaemia,Umberto I Hospital, Siracusa, Italy; Department of Thalassaemia, Garibaldi Hospital, Catania, Italy; Department of Hematology, Hamad Medical Center (HMC), Doha, Qatar.

 

 

Abstract

The commonest form of thyroid dysfunction seen in subjects with TM is primary hypothyroidism due to abnormalities of the thyroid gland. Central hypothyroidism (CH) has been reported as an uncommon clinical entity in TM patients although the anterior pituitary gland is particularly sensitive to free radical oxidative stresses. Diagnosis is usually made on a biochemical basis showing low circulating concentrations of thyroid hormone associated with an inappropriately low TSH levels. The diagnosis is not clinically obvious and a basal normal TSH level does not exclude the diagnosis of CH. Therefore, it is important that clinicians accurately interpret thyroid function tests. In TM patients, CH prevalence differs at different ages is unknown and it is not easy to diagnose because most of the symptoms of CH are non specific and are frequently attributed to anaemia or other associated complications. We performed a cross-sectional analysis on a large database using the clinical records of our TM patients to explore the prevalence of CH in prepubertal (patients; 13 males) peripubertal (between 11 and 16 years: 9 patients; 3 males), and pubertal TM subjects (>16 years: 305 patients; 164 males). Central hypothyroidism was present in 26 (7,6%) TM patients. Their mean age was 29.9±8.4 years, 14 (53.8%) were males and 12 (46.1%) were females. The prevalence of CH was 6% in patients with a chronological age below 21 years and 7.9% in those above 21 years. Clinicians should be alert for the diagnosis of CH through accurate interpretation of thyroid function tests. We recommend L-thyroxine therapy if the level of FT4 is consistently low provided that the patient has normal cortisol levels. 
 
 
 

Altri post della stessa categoria

Richiedi la tua visita online

Quisisana offre la possibilità di richiedere la prenotazione delle visite specialistiche direttamente online.

Informativa

Noi e terze parti selezionate (come ad esempio Google, Facebook, LinkedIn, ecc.) utilizziamo cookie o tecnologie simili per finalità tecniche e, con il tuo consenso, anche per altre finalità come ad esempio per mostrati annunci personalizzati e non personalizzati più utili per te, come specificato nella .
Chiudendo questo banner con la crocetta o cliccando su "Rifiuta", verranno utilizzati solamente cookie tecnici. Se vuoi selezionare i cookie da installare, clicca su "Personalizza". Se preferisci, puoi acconsentire all'utilizzo di tutti i cookie, anche diversi da quelli tecnici, cliccando su "Accetta tutti". In qualsiasi momento potrai modificare la scelta effettuata.